Rapid Micro Biosystems (RPID) Debt Ratio (2020 - 2026)

Name: Rapid Micro Biosystems (RPID) Debt Ratio (2020 - 2026) | Business Quant
Creator: Business Quant

Rapid Micro Biosystems recorded quarterly Debt Ratio of 0.31 in Q1 2026, up 20.99% quarter-over-quarter from 0.25 in Q4 2025.

Rapid Micro Biosystems' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.31 for Q1 2026.

In Q1 2026, Debt Ratio changed N/A year-over-year to 0.31; the TTM figure through Mar 2026 stood at 0.31 (changed N/A YoY), while the FY2025 annual figure was 0.25, changed N/A from the prior year.
Debt Ratio came in at 0.31 for Q1 2026 at Rapid Micro Biosystems, up from 0.25 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.31 in Q1 2026 to a low of 0.22 in Q3 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	0.31
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	0.32
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	0.31
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.25
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	0.27
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	0.18
10	Rapid Micro Biosystems	89.50 Mn	66.56 Mn	371,000.00	0.31

Download Data 🔒